Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Pharmacokinetic and Pharmacodynamic Study of NPI-001 Oral Solution Compared to Cysteamine Bitartrate in Cystinosis Patients

NCT05994534 is registered in ClinicalTrials.gov with Nacuity Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05994534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05994534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Pharmacokinetic and Pharmacodynamic Study of NPI-001 Oral Solution Compared to Cysteamine Bitartrate in Cystinosis Patients
Lead sponsor
Nacuity Pharmaceuticals, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
October 29, 2023
Completion date
May 26, 2026
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystinosis